APA (7th ed.) Citation

J, V. D., SR, B., F, L., K, Z., NS, B., E, G., . . . F, N. (2026). Rapamycin treatment ameliorates HLA-B27-mediated gut inflammation and alters the microbiome in experimental spondyloarthritis. Frontiers in immunology, 17, 1755132. https://doi.org/10.3389/fimmu.2026.1755132

Chicago Style (17th ed.) Citation

J, Van Doorn, et al. "Rapamycin Treatment Ameliorates HLA-B27-mediated Gut Inflammation and Alters the Microbiome in Experimental Spondyloarthritis." Frontiers in Immunology 17 (2026): 1755132. https://doi.org/10.3389/fimmu.2026.1755132.

MLA (9th ed.) Citation

J, Van Doorn, et al. "Rapamycin Treatment Ameliorates HLA-B27-mediated Gut Inflammation and Alters the Microbiome in Experimental Spondyloarthritis." Frontiers in Immunology, vol. 17, 2026, p. 1755132, https://doi.org/10.3389/fimmu.2026.1755132.